FlightPath (Drug Discovery)

Developer of antibiotic therapies designed to treat pathogen-driven diseases. The company's therapies kill co-infectious bacteria in Lyme disease to limit microbiome damage and treat multiple pathogen...

Healthcare
Berkeley, CA, United States
Founded 2019
2 employees
Website
Valuation
$21M
Market implied
Share Price
N/A
Total Raised
$9.7M
Last Round
N/A

Get the full picture

Create a free account to unlock FlightPath (Drug Discovery)'s funding history, team members, investor details, and more.

15 free profiles/month · No credit card required